168
Views
12
CrossRef citations to date
0
Altmetric
Clinical Focus; ADHD, Psychiatric Disorders, and Stroke and Neurology

Attention Benefits after a Single Dose of Metadoxine Extended Release in Adults with Predominantly Inattentive ADHD

, MD, , MD, MBA, , PhD, MBA & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Antonio Molina-Carballo, Ana Checa-Ros & Antonio Muñoz-Hoyos. (2016) Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opinion on Therapeutic Patents 26:7, pages 799-814.
Read now
Massimiliano Buoli, Marta Serati & Wiepke Cahn. (2016) Alternative pharmacological strategies for adult ADHD treatment: a systematic review. Expert Review of Neurotherapeutics 16:2, pages 131-144.
Read now

Articles from other publishers (10)

Eric R. Braverman, Catherine A. Dennen, Mark S. Gold, Abdalla Bowirrat, Ashim Gupta, David Baron, A. Kenison Roy, David E. Smith, Jean Lud Cadet & Kenneth Blum. (2022) Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”. International Journal of Environmental Research and Public Health 19:9, pages 5480.
Crossref
Joseph Ben-Sheetrit, Hanan Tasker, Lee Avnat, Pavel Golubchik, Abraham Weizman & Iris Manor. (2017) Possible Age-Related Progression of Attentional Impairment in ADHD and Its Attenuation by Past Diagnosis and Treatment. Journal of Attention Disorders 25:1, pages 14-21.
Crossref
Lisa WeyandtCaroline SweeneyLauren Thompson. (2020) The Effectiveness of Stimulant Medication at Improving Executive Functioning in Adults with ADHD. The ADHD Report 28:7, pages 1-8.
Crossref
Federico Mucci, Maria Teresa Avella & Donatella Marazziti. (2019) ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan. Current Medicinal Chemistry 26:38, pages 6942-6969.
Crossref
Kaizad MunshiKatherine PawlowskiJoseph Gonzalez-HeydrichJonathan D. Picker. (2017) Review of Salient Investigational Drugs for the Treatment of Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology 27:10, pages 850-863.
Crossref
Margaret C. Grabb & Jogarao V.S. Gobburu. (2017) Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology. Progress in Neurobiology 152, pages 38-57.
Crossref
Aia E. Jønch & Sébastien Jacquemont. 2017. Fragile X Syndrome. Fragile X Syndrome 419 441 .
Andrew Ligsay, Randi Hagerman & Elizabeth Berry-Kravis. 2017. Fragile X Syndrome. Fragile X Syndrome 401 418 .
Elisabeth Toverud Landaas, Tore Ivar Malmei Aarsland, Arve Ulvik, Anne Halmøy, Per Magne Ueland & Jan Haavik. (2018) Vitamin levels in adults with ADHD. BJPsych Open 2:6, pages 377-384.
Crossref
Fátima Higuera-de la Tijera. (2015) Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis. World Journal of Gastroenterology 21:16, pages 4975.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.